Clinical outcomes using a 3D printed tandem-needle-template and the EMBRACE-II planning aims for image guided adaptive brachytherapy in locally advanced cervical cancer

References

• Tanderup K, Fokdal LU, Sturdza A, et al. Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer. Radiother Oncol. 2016;120(3):441–446. doi: 10.1016/j.radonc.2016.05.014.
   PubMed Web of Science ®Google Scholar
• Sturdza A, Pötter R, Fokdal LU, et al. Image guided brachytherapy in locally advanced cervical cancer: improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study. Radiother Oncol. 2016;120(3):428–433. doi: 10.1016/j.radonc.2016.03.011.
   PubMed Web of Science ®Google Scholar
• Lindegaard JC, Fokdal LU, Nielsen SK, et al. MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a nordic perspective. Acta Oncol. 2013;52(7):1510–1519. doi: 10.3109/0284186X.2013.818253.
   PubMed Web of Science ®Google Scholar
• Ribeiro I, Janssen H, de Brabandere M, et al. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients. Radiother Oncol. 2016;120(3):447–454. doi: 10.1016/j.radonc.2016.04.016.
   PubMed Web of Science ®Google Scholar
• Pötter R, Tanderup K, Kirisits C, et al. The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies. Clin Transl Radiat Oncol. 2018;9:48–60. doi: 10.1016/j.ctro.2018.01.001.
   PubMed Web of Science ®Google Scholar
• Pötter R, Haie-Meder C, van Limbergen E, et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy - 3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol. 2006;78(1):67–77. doi: 10.1016/j.radonc.2005.11.014.
   PubMed Web of Science ®Google Scholar
• Haie-Meder C, Pötter R, van Limbergen E, et al. Recommendations from gynaecological (GYN) GEC-ESTRO working group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol. 2005;74(3):235–245. doi: 10.1016/j.radonc.2004.12.015.
   PubMed Web of Science ®Google Scholar
• Fokdal L, Sturdza A, Mazeron R, et al. Image guided adaptive brachytherapy with combined intracavitary and interstitial technique improves the therapeutic ratio in locally advanced cervical cancer: analysis from the retroEMBRACE study. Radiother Oncol. 2016;120(3):434–440. doi: 10.1016/j.radonc.2016.03.020.
   PubMed Web of Science ®Google Scholar
• Kirisits C, Lang S, Dimopoulos J, et al. The vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results. Int J Radiat Oncol Biol Phys. 2006;65(2):624–630. doi: 10.1016/j.ijrobp.2006.01.036.
   PubMed Web of Science ®Google Scholar
• Tan MMFML, Tanderup PK, Kirisits PC, et al. Image-guided adaptive radiotherapy in cervical cancer. Semin Radiat Oncol. 2019;29(3):284–298. doi: 10.1016/j.semradonc.2019.02.010.
   PubMed Web of Science ®Google Scholar
• Nomden CN, de Leeuw AAC, Roesink JM, et al. Clinical outcome and dosimetric parameters of chemo-radiation including MRI guided adaptive brachytherapy with tandem-ovoid applicators for cervical cancer patients: a single institution experience. Radiother Oncol. 2013;107(1):69–74. doi: 10.1016/j.radonc.2013.04.006.
   PubMed Web of Science ®Google Scholar
• Lindegaard JC, Tanderup K, Nielsen SK, et al. MRI-Guided 3D optimization significantly improves DVH parameters of Pulsed-Dose-Rate brachytherapy in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys. 2008;71(3):756–764. doi: 10.1016/j.ijrobp.2007.10.032.
   PubMed Web of Science ®Google Scholar
• Petric P, Hudej R, Music M. MRI assisted cervix cancer brachytherapy pre-planning, based on insertion of the applicator in Para-cervical anaesthesia: preliminary results of a prospective study. J Contemp Brachytherapy. 2009;1(3):163–169.
   PubMedGoogle Scholar
• Mahantshetty U, Sturdza A, Naga Ch P, et al. Vienna-II ring applicator for distal parametrial/pelvic wall disease in cervical cancer brachytherapy: an experience from two institutions: clinical feasibility and outcome. Radiother Oncol. 2019;141:123–129. doi: 10.1016/j.radonc.2019.08.004.
   PubMed Web of Science ®Google Scholar
• Rogowski P, Rottler M, Walter F, et al. Clinical outcome of combined intracavitary/interstitial brachytherapy using a hybrid applicator in locally advanced cervical cancer. Gynecol Oncol. 2022;166(3):576–581. doi: 10.1016/j.ygyno.2022.06.019.
   PubMed Web of Science ®Google Scholar
• Kissel M, Fournier-Bidoz N, Henry O, et al. Venezia applicator with oblique needles improves clinical target volume coverage in distal parametrial tumor residue compared to parallel needles only. J Contemp Brachytherapy. 2021;13(1):24–31. doi: 10.5114/jcb.2021.103583.
   PubMed Web of Science ®Google Scholar
• Keller A, Rodríguez-López JL, Patel AK, et al. Early outcomes after definitive chemoradiation therapy with vienna/venezia hybrid high-dose rate brachytherapy applicators for cervical cancer: a single-institution experience. Brachytherapy. 2021;20(1):104–111. In: elsevier Incdoi: 10.1016/j.brachy.2020.08.006.
   PubMed Web of Science ®Google Scholar
• Lindegaard JC, Madsen ML, Traberg A, et al. Individualised 3D printed vaginal template for MRI guided brachytherapy in locally advanced cervical cancer. Radiother Oncol. 2016;118(1):173–175. doi: 10.1016/j.radonc.2015.12.012.
   PubMed Web of Science ®Google Scholar
• Logar HBZ, Hudej R, Šegedin B. Development and assessment of 3D-printed individual applicators in gynecological MRI-guided brachytherapy. J Contemp Brachytherapy. 2019;11(2):128–136. doi: 10.5114/jcb.2019.84741.
   PubMed Web of Science ®Google Scholar
• Marar M, Simiele E, Niedermayr T, et al. Applying 3D-Printed templates in High-Dose-Rate brachytherapy for cervix cancer: simplified needle insertion for optimized dosimetry. Int J Radiat Oncol Biol Phys. 2022;114(1):111–119. doi: 10.1016/j.ijrobp.2022.05.027.
   PubMed Web of Science ®Google Scholar
• Marar M, Niedermayr T, Kidd E. Developing next generation 3D-printing for cervical cancer hybrid brachytherapy: a guided interstitial technique enabling improved flexibility, dosimetry, and efficiency. Int J Radiat Oncol Biol Phys. 2023; doi: 10.1016/j.ijrobp.2023.04.005.
   PubMed Web of Science ®Google Scholar
• Bhatla N, Aoki D, Sharma DN, et al. Cancer of the cervix uteri. Int J Gynaecol Obstet. 2018;143 Suppl 2:22–36. doi: 10.1002/ijgo.12611.
   PubMed Web of Science ®Google Scholar
• Lindegaard JC, Petric P, Lindegaard AM, et al. Evaluation of a new prognostic tumor score in locally advanced cervical cancer integrating clinical examination and magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 2020;106(4):754–763. doi: 10.1016/j.ijrobp.2019.11.031.
   PubMed Web of Science ®Google Scholar
• Lindegaard JC, Petric P, Schmid MP, et al. Prognostic implications of uterine cervical cancer regression During chemoradiation evaluated by the T-Score in the multicenter EMBRACE I study. Int J Radiat Oncol Biol Phys. 2022;113(2):379–389. doi: 10.1016/j.ijrobp.2022.02.005.
   PubMed Web of Science ®Google Scholar
• Fokdal L, Tanderup K, Hokland SB, et al. Clinical feasibility of combined intracavitary/interstitial brachytherapy in locally advanced cervical cancer employing MRI with a tandem/ring applicator in situ and virtual preplanning of the interstitial component. Radiother Oncol. 2013;107(1):63–68. doi: 10.1016/j.radonc.2013.01.010.
   PubMed Web of Science ®Google Scholar
• Tanderup K, Fokdal LU, Lindegaard JC, et al. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study. Lancet Oncol. 2021;22(4):538–547. doi: 10.1016/S1470-2045(20)30753-1.
   PubMed Web of Science ®Google Scholar
• Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340(15):1144–1153. doi: 10.1056/NEJM199904153401502.
   PubMed Web of Science ®Google Scholar
• Schmid MP, Lindegaard JC, Mahantshetty U, et al. Risk factors for local failure Following chemoradiation and magnetic resonance Image-Guided brachytherapy in locally advanced cervical cancer: results From the EMBRACE-I study. J Clin Oncol. 2023;41(10):1933–1942.
   PubMed Web of Science ®Google Scholar
• Walter F, Maihöfer C, Schüttrumpf L, et al. Combined intracavitary and interstitial brachytherapy of cervical cancer using the novel hybrid applicator venezia: clinical feasibility and initial results. Brachytherapy. 2018;17(5):775–781. doi: 10.1016/j.brachy.2018.05.009.
   PubMed Web of Science ®Google Scholar
• Grover S, Xu M, Jhingran A, et al. Clinical trials in low and Middle-income countries—successes and challenges. Gynecol Oncol Rep. 2017;19:5–9. doi: 10.1016/j.gore.2016.11.007.
   PubMedGoogle Scholar
• Mohamed S, Lindegaard JC, de Leeuw AAC, et al. Vaginal dose de-escalation in image guided adaptive brachytherapy for locally advanced cervical cancer. Radiother Oncol. 2016;120(3):480–485. doi: 10.1016/j.radonc.2016.05.020.
   PubMed Web of Science ®Google Scholar